{"componentChunkName":"component---src-templates-chapter-level-1-chapter-level-1-tsx","path":"/topics/rosacea/references/","result":{"pageContext":{"chapter":{"id":"40a50d91-c85e-5b2c-b283-ca2a9f30c6f0","slug":"references","fullItemName":"References","depth":1,"htmlHeader":"<!-- begin field 8216dda2-b074-4269-bbcf-e5d1e26cb0d5 --><h1>References</h1><!-- end field 8216dda2-b074-4269-bbcf-e5d1e26cb0d5 -->","summary":null,"htmlStringContent":"<!-- begin item f3a1a64b-3588-42ae-b1e6-975a96ecc5dc --><!-- begin field cb170e89-14a8-441f-add3-f2eff84863f2 --><ul class=\"bibliography\"><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Aldrich, N., Gerstenblith, M., Fu, P., Tuttle, M.S., Varma, P., Gotow, E.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Genetic vs environmental factors that correlate with rosacea: a cohort-based survey of twins</span>. <em>JAMA Dermatology</em> <strong><span rel=\"bibo:volume\">151</span></strong>(<span rel=\"bibo:issue\">11</span>),  1213-1219. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26307938\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"72c77749-1495-490c-b033-abf200abac7a\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Alexis, A.F., Callender, V.D., Baldwin, H.E.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2019</span>) <span property=\"dc:title\">Global epidemiology and clinical spectrum of rosacea, highlighting skin of color: review and practical clinical experience</span>. <em>Journal of the American Academy of Dermatology</em> <strong><span rel=\"bibo:volume\">80</span></strong>(<span rel=\"bibo:issue\">6</span>),  1722-1729. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/30240779\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"83406641-0ed8-4de9-bcf2-abf200ac1064\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Berg, M. and Liden, S.                </span> (<span property=\"dcterms:issued\">1989</span>) <span property=\"dc:title\">An epidemiological study of rosacea</span>. <em>Acta Dermato-Venereologica</em> <strong><span rel=\"bibo:volume\">69</span></strong>(<span rel=\"bibo:issue\">5</span>),  419-423. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/2572109\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"07b86070-4138-4934-af94-abf200ac3cbe\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Blount, B.W. and Pelletier, A.L.                </span> (<span property=\"dcterms:issued\">2002</span>) <span property=\"dc:title\">Rosacea: a common, yet commonly overlooked, condition</span>. <em>American Family Physician</em> <strong><span rel=\"bibo:volume\">66</span></strong>(<span rel=\"bibo:issue\">3</span>),  435-440. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/12182520\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"058a715d-4733-4db5-a4f1-abf200ac5bdd\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Chang, Y-S. and Huang, Y-S.                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Role of demodex mite infestation in rosacea: a systematic review and meta-analysis</span>. <em>Journal of the American Academy of Dermatology</em> <strong><span rel=\"bibo:volume\">77</span></strong>(<span rel=\"bibo:issue\">3</span>),  441-447. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/28711190\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"9a4beceb-1b65-429b-8d80-abf200ac877f\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    College of Optometrists                </span> (<span property=\"dcterms:issued\">2018</span>) <em><span property=\"dc:title\">Ocular rosacea</span></em>. <span property=\"dc:publisher\">College of Optometrists</span>. <span rel=\"bibo:Website\"><a href=\"http://www.college-optometrists.org/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2b329014-c0b2-4d84-bc70-abf200acb678\">http://www.college-optometrists.org</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.college-optometrists.org/guidance/clinical-management-guidelines/ocular-rosacea.html\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"98a89351-a9ad-4fac-b748-abf200acb6a4\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Coutinho, J.C., Westphal, D.C., Lobato, L.C.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Rosacea fulminans: unusual clinical presentation of rosacea</span>. <em>Anais Brasileiros de Dermatologia</em> <strong><span rel=\"bibo:volume\">95</span></strong>(<span rel=\"bibo:issue\">5 Suppl 1</span>),  151-153. [<span rel=\"bibo:uri\"><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325025/#:~:text=Rosacea%20fulminans%20or%20pyoderma%20faciale,with%20red-cyanotic%20centrofacial%20erythema.\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"40584530-be78-4776-89bd-abf200ad2e50\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Culp, B. and Scheinfeld, N.                </span> (<span property=\"dcterms:issued\">2009</span>) <span property=\"dc:title\">Rosacea: a review.</span> <em>P&amp;T</em> <strong><span rel=\"bibo:volume\">34</span></strong>(<span rel=\"bibo:issue\">1</span>),  38-45. [<span rel=\"bibo:abstract\"><a href=\"http://www.ncbi.nlm.nih.gov/pubmed/19562004\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"805b0c4f-6205-46dc-aa2d-ac0600f8c5fe\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Del Rosso, J.Q., Tanghetti, E., Webster, G.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2019</span>) <span property=\"dc:title\">Update on the management of rosacea from the American Acne and Rosacea Society (AARS)</span>. <em>Journal of Clinical and Aesthetic Dermatology</em> <strong><span rel=\"bibo:volume\">12</span></strong>(<span rel=\"bibo:issue\">6</span>),  17-24. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/31360284\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"04a2490a-3d3b-4e57-aba7-abf200ada447\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Gallo, R.L., Granstein, R.D., Kang, S.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Standard classification and pathophysiology of rosacea: the 2017 update by the National Rosacea Society expert committee</span>. <em>Journal of the American Academy of Dermatology</em> <strong><span rel=\"bibo:volume\">78</span></strong>(<span rel=\"bibo:issue\">1</span>),  148-155. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29089180\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"41a5b10a-fa93-4c0c-ae61-abf200ae1f00\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Gether, L., Overgaard, L.K., Egeberg, A. and Thysson, J.P.                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Incidence and prevalence of rosacea: a systematic review and meta-analysis</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">179</span></strong>(<span rel=\"bibo:issue\">2</span>),  282-289. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29478264\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"258155a9-f7ed-4453-bb4f-abf200ae64ad\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Joint Formulary Committee                </span> (<span property=\"dcterms:issued\">2020</span>) <em><span property=\"dc:title\">British National Formulary (online)</span></em>. <span property=\"dc:publisher\">BMJ Group and Pharmaceutical Press</span>. <span rel=\"bibo:Website\"><a href=\"https://bnf.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"b4831da1-0e54-4f74-93de-abb800fcec62\">https://bnf.nice.org.uk</a></span>            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Knight, A.G. and Vickers, C.F.H.                </span> (<span property=\"dcterms:issued\">1975</span>) <span property=\"dc:title\">A follow-up of tetracycline-treated rosacea with special reference to rosacea keratitis</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">93</span></strong>(<span rel=\"bibo:issue\">5</span>),  577-580. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/128376\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"4230ce22-d8d2-4447-aed4-abf200aeb590\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Lee, W.J., Lee, Y.J., Lee, M.H.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Prognosis of 234 rosacea patients according to clinical subtype: the significance of central facial erythema in the prognosis of rosacea</span>. <em>Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">43</span></strong>(<span rel=\"bibo:issue\">5</span>),  526-531. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26507367\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"f868be8d-4696-4507-b910-abf200b30269\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    MHRA                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">Brimonidine gel (Mirvaso▼): risk of exacerbation of rosacea</span></em>. <span property=\"dc:publisher\">Medicines and Healthcare products Regulatory Agency</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/drug-safety-update\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"0fe61e53-3fb6-4c67-ab3c-ac030061aba6\">http://www.gov.uk/drug-safety-update</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/drug-safety-update/brimonidine-gel-mirvaso-risk-of-exacerbation-of-rosacea\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"31775311-96b3-4741-aea2-ac030061abc4\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    MHRA                </span> (<span property=\"dcterms:issued\">2017</span>) <em><span property=\"dc:title\">Brimonidine gel (Mirvaso): risk of systemic cardiovascular effects; not to be applied to damaged skin</span></em>. <span property=\"dc:publisher\">Medicines and Healthcare products Regulatory Agency</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"2fb3df76-2b62-4f23-9bee-abf200b33823\">http://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/drug-safety-update/brimonidine-gel-mirvaso-risk-of-systemic-cardiovascular-effects-not-to-be-applied-to-damaged-skin\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"ab9bfe20-8434-46db-b892-abf200b338b4\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    MHRA                </span> (<span property=\"dcterms:issued\">2020</span>) <em><span property=\"dc:title\">Erythromycin: caution required due to cardiac risks (QT interval prolongation); drug interaction with rivaroxaban</span></em>. <span property=\"dc:publisher\">Medicines and Healthcare products Regulatory Agency</span>. <span rel=\"bibo:Website\"><a href=\"http://www.gov.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"b46bfac9-4c93-4b7b-964f-acbc00994b8c\">http://www.gov.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.gov.uk/drug-safety-update/erythromycin-caution-required-due-to-cardiac-risks-qt-interval-prolongation-drug-interaction-with-rivaroxaban\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"9b77fdab-9c66-46f6-86f2-acbc00994b8c\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2014</span>) <em><span property=\"dc:title\">Facial erythema of rosacea: brimonidine tartrate gel (ESNM43)</span></em>. <span property=\"bibo:Collection\">NICE advice</span>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"https://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"c88f8f18-a7f0-43f6-9a22-abf200b3665e\">https://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/advice/esnm43/chapter/key-points-from-the-evidence\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"dddd9574-0c9f-4ede-8361-abf200b36679\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    NICE                </span> (<span property=\"dcterms:issued\">2016</span>) <em><span property=\"dc:title\">Inflammatory lesions of papulopustular rosacea: ivermectin 10mg/g cream</span></em>. <span property=\"dc:publisher\">National Institute for Health and Care Excellence</span>. <span rel=\"bibo:Website\"><a href=\"http://www.nice.org.uk/\" target=\"_blank\" class=\"website\" data-hyperlink-id=\"25dc527d-5a0d-4639-aa25-abf200b4ced5\">http://www.nice.org.uk</a></span> [<span rel=\"bibo:uri\"><a href=\"https://www.nice.org.uk/advice/esnm68/chapter/full-evidence-summary#introduction-and-current-guidance-2\" target=\"_blank\" class=\"fulltextlink\" data-hyperlink-id=\"fdf74178-cc53-4ba3-a0a1-abf200b4cf04\">Free Full-text</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Oge, L.K., Muncie, H.L. and Philips-Savoy, A.R.                </span> (<span property=\"dcterms:issued\">2015</span>) <span property=\"dc:title\">Rosacea: diagnosis and treatment</span>. <em>American Family Physician</em> <strong><span rel=\"bibo:volume\">92</span></strong>(<span rel=\"bibo:issue\">3</span>),  187-196. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26280139\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"dad72eb1-13a9-4234-b59e-abf200b683a6\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Schaller, M., Almeida, L.M.C., Bewley, A., Cribier, B., Dlova, N.C., Kautz, G.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Rosacea treatment update: recommendations from the global ROSacea COnsensus (ROSCO) panel</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">176</span></strong>(<span rel=\"bibo:issue\">2</span>),  465-471. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/27861741\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"53cf467b-eefe-4216-b2c1-abf200b6c7e0\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Schaller, M., Almeida, L.M.C., Bewley, A., Cribier, B., Del Rosso, J., Dlova, N.C.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2020</span>) <span property=\"dc:title\">Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">182</span></strong>(<span rel=\"bibo:issue\">5</span>),  1269-1276. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/31392722\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"6a03e2a1-dce4-4112-a0ed-abf200b71250\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Steinhoff, M., Schauber, J. and Leyden, J.J.                </span> (<span property=\"dcterms:issued\">2013</span>) <span property=\"dc:title\">New insights into rosacea pathophysiology: a review of recent findings</span>. <em>Journal of the American Academy of Dermatology</em> <strong><span rel=\"bibo:volume\">69</span></strong>(<span rel=\"bibo:issue\">6 Supp 1</span>),  S15-S26. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/24229632\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"6deb38a9-667d-4250-8eb7-abf200b73828\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Tan, J., Schofer, H., Araviiskaia, E.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2016</span>) <span property=\"dc:title\">Prevalence of rosacea in the general population of Germany and Russia - the RISE study</span>. <em>Journal of the European Academy of Dermatology and Venereology</em> <strong><span rel=\"bibo:volume\">30</span></strong>(<span rel=\"bibo:issue\">3</span>),  428-434. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/26915718\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"44654d8c-bee7-4021-b3ee-abf200b7cfec\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Tan, J., Almeida, L.M.C., Bewley, A., Cribier, B., Dlova, N.C., Gallo. R.                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Updating the diagnosis, classification and assessment of rosacea: recommendations for the Global ROSacea COnsensus (ROSCO) panel</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">176</span></strong>(<span rel=\"bibo:issue\">2</span>),  431-438. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/27718519\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"357db6f9-80e7-4b33-a38f-abf100e33719\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    Tan, J., Berg, M., Gallo, R.L. and Del Rosso, J.Q.                </span> (<span property=\"dcterms:issued\">2018</span>) <span property=\"dc:title\">Applying the phenotype approach for rosacea to practice and research</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">179</span></strong>(<span rel=\"bibo:issue\">3</span>),  741-746. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29799114\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"442a3896-4cb0-4c17-ac51-abf200b7778d\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    van Zuuren, E.J.                </span> (<span property=\"dcterms:issued\">2017</span>) <span property=\"dc:title\">Rosacea</span>. <em>New England Journal of Medicine</em> <strong><span rel=\"bibo:volume\">377</span></strong>(<span rel=\"bibo:issue\">18</span>),  1754-1764. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/29091565\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"3bb58d07-ca62-42c1-be28-abf200b7eae5\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    van Zuuren, E.J., Fedorowicz, Z., Tan, J.,                        <em>et al.</em>                </span> (<span property=\"dcterms:issued\">2019</span>) <span property=\"dc:title\">Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">181</span></strong>(<span rel=\"bibo:issue\">1</span>),  65-79. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/30585305\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"688b1da5-e6e1-4621-8657-abf200b84dfd\">Abstract</a></span>]            </span></li><li><span property=\"bibo:Article\">                <span property=\"bibo:authorList\">                    van Zuuren, E.J., van der Linden, M.M.D. and Arents, B.W.M.                </span> (<span property=\"dcterms:issued\">2020</span>) <span property=\"dc:title\">Rosacea treatment guideline for the Netherlands</span>. <em>British Journal of Dermatology</em> <strong><span rel=\"bibo:volume\">182</span></strong>(<span rel=\"bibo:issue\">6</span>),  1504-1506. [<span rel=\"bibo:abstract\"><a href=\"https://pubmed.ncbi.nlm.nih.gov/31970753\" target=\"_blank\" class=\"abstract\" data-hyperlink-id=\"bd51ee29-0cb1-49d2-8314-abf200b869e2\">Abstract</a></span>]            </span></li></ul><!-- end field cb170e89-14a8-441f-add3-f2eff84863f2 --><!-- end item f3a1a64b-3588-42ae-b1e6-975a96ecc5dc -->","topic":{"id":"907deb55-501c-50b0-9c07-5956c70cf201","topicId":"d6855039-5025-454d-b195-d4b0a3763978","topicName":"Rosacea ","slug":"rosacea","lastRevised":"Last revised in January 2021","chapters":[{"id":"a3d8bb8f-cf98-5320-abe8-71c7b0c3d604","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"a9c3b514-8e94-52d5-8de7-2caedcdd8ed3","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"efe24f29-88ad-5507-b4b5-ec00c54a404d","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"10634254-4474-5303-9337-e3682fd14514","slug":"changes","fullItemName":"Changes"},{"id":"1ad5ada5-1ed7-5223-b60c-122b20127e1e","slug":"update","fullItemName":"Update"}]},{"id":"832a95da-0571-5031-b437-3cc5568bc7fa","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"59d41997-63c3-57d4-8c29-c4655d090e7a","slug":"goals","fullItemName":"Goals"},{"id":"2c3bc0a5-be4b-5a98-a5d8-02e7cb85b9cb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f8c34a65-7879-5a21-87df-68739ba5d1f3","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9f050a9b-10be-5d79-b662-0099ac611890","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9fcdbb11-1f96-5ae9-aeec-617a9da55e12","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"538579d3-7620-5145-a70f-022ec13226ae","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d0b606da-7836-5c33-8390-23a6dad9e7bd","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"ed198aaf-1444-5590-ab74-c9fdff996b5e","slug":"definition","fullItemName":"Definition"},{"id":"df406671-3834-580f-836a-3c2428245359","slug":"prevalence","fullItemName":"Prevalence"},{"id":"be28c459-5653-506e-937c-5c4d2f7ceecd","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"bc98e144-7d7d-5fa2-97ad-7c1bd8526ca0","slug":"complications","fullItemName":"Complications"},{"id":"1a5cbcf6-2870-5a82-a207-8c8888f907d2","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"d654b61f-b47e-5123-b965-f806f0eb2e6d","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"bd6d5455-d63e-5507-8bdd-028b338047cc","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"30d3265f-84ec-5ac7-a410-bc11cd078ac9","slug":"assessment","fullItemName":"Assessment"},{"id":"e111154d-c82a-5292-b201-f4a12a8a4d17","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"e753e991-54fe-5ab5-96d2-124372f1292f","fullItemName":"Management","slug":"management","subChapters":[{"id":"0e7b3ebf-33f5-5b51-a9ab-81c8dda1332f","slug":"rosacea","fullItemName":"Scenario: Rosacea"}]},{"id":"602c95a0-f64e-593e-85c4-798ea728733b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"e6e7bc13-b6bd-5b5e-b337-196c3291ee63","slug":"topical-treatments","fullItemName":"Topical treatments"},{"id":"c53198f5-f60b-5fb6-8767-9f9a275329f5","slug":"oral-antibiotics","fullItemName":"Oral antibiotics"}]},{"id":"0db34d3f-c02f-5b8f-8498-90541139bc2a","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ca47aba9-e0da-5e0a-a1a2-46bfab6fe609","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"5c0a0103-4ed2-586f-8fbd-aaf6fe82f548","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"84966474-462f-592c-b43d-474d1ca89d52","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"bb2d8252-c981-52ba-9faf-d9e9450efe7c","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f5e586ed-912a-51ab-b246-3a6f6c67e2d1","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"a60f4af9-1a6a-5a71-9310-2b3fe7d0cb92","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"40a50d91-c85e-5b2c-b283-ca2a9f30c6f0","fullItemName":"References","slug":"references","subChapters":[]}]},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}